Skip to content
Recall Observatory FDA recall evidence

Drug product

Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01

D-1184-2018

August 28, 2018

Class III

Product summary

Firm
Pfizer Inc.
Event
Event 80923
Status
Terminated
Classification
Class III
Quantity
1,580 vials
Official record key
drug-enforcement:D-1184-2018

Official wording

Reason: Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point

Code information: Lot: DP602, 10/2018

Distribution pattern: Nationwide USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification